Skip to main content

Life sciences

The life sciences industry is rapidly changing and highly regulated. We act for clients across the health sector, including NHS Commissioners, NHS and independent health providers and established healthtech companies and start-ups, meaning we’re uniquely placed to manage these challenges and guide clients through regulatory and contractual processes.   

Medical devices, appliances and apps are usually highly technical, meaning they are of high value. This means they need to go through extremely rigorous regulatory processes and testing before they can secure approval for use in the market.   

At Browne Jacobson, we have specialised teams that advise on different areas of the life sciences sector. Our expertise covers intellectual property (contentious and non-contentious), regulatory, commercial, procurement, data protection, dispute resolution and value add services. 

Much of our advice is proactive, guiding clients on the development of new products and services, entry to the UK market, business restructuring or in respect of ongoing regulatory compliance. We’re regularly asked to advise on MHRA regulation, CQC registration, trademark registration, data processing requirements and NHS Provider licensing. 

Our expertise also extends to advising clients on the challenges of dealing with digital disruption and digital transformation, including advising on the issues at the forefront of society in the context of those challenges.  

Featured experience

Acquisition of Quotient Clinical

Advising management on the acquisition of Quotient Clinical, a provider of outsourced, early stage drug development services to the pharmaceutical industry, from the Quotient Bioresearch Group by Bridgepoint Development Capital.

Bioproject Pharma S.á.r.l

Advising Bioprojet Pharma S.á.r.l on the UK aspects of a £10.2 million acquisition of Lincoln Medical Limited, which provides drug delivery systems for the treatment of anaphylactic shock.

Crown Bioscience Inc's acquisition

Acting on Crown Bioscience Inc’s acquisition of Precos - a leading pre-clinical research and development service provider with a focus on oncology.

Defence of allegations of patent infringement

Acting for a household name in the health sector in defence of allegations of patent infringement in respect of a therapeutically-crucial diagnostic test.


Latest insights and events